1653. Promoting the Value of the ID Physician
Session: Symposium: ID Physicians in the Age of Value-Based Healthcare
Friday, October 5, 2018: 3:55 PM
Room: S 206-208
Susan C. Bleasdale, MD, Division of Infectious Diseases, University of Illinois Hospital & Health Sciences System, Chicago, IL

Susan C. Bleasdale, MD Associate Professor of Clinical Medicine Medical Director Infection Prevention & Control, University of Illinois Hospital (UIH) Antimicrobial Stewardship Medical Director, UIH Dr. Bleasdale is the physician lead for infection prevention and antimicrobial stewardship at the University of Illinois Hospital and Health Sciences System (UIH) and is a leader in related research. In administrative roles, she directs initiatives to reduce HAIs, infections with multidrug resistant organisms (MDROs), and improve antimicrobial prescribing. In research, she was the lead investigator for one of the first studies of chlorhexidine gluconate (CHG) use to reduce blood stream infections in intensive care unit patients. Current research activity is related to the epidemiology of HAIs and MDROs, the study of interventions to reduce HAIs and improve antibiotic stewardship, and antimicrobial clinical trials. Dr. Bleasdale is a lead investigator for a study to reduce surgical site infections as part of the CDC Epicenters for Prevention of Healthcare Associated Infections (HAIs). She has been part of previous Epicenter work studying the transmission of HAIs via healthcare workers and the effective use of personal protective equipment to prevent transmission. In addition, she is currently working on inpatient and ambulatory antimicrobial stewardship interventions. Her clinical practice is general infectious disease and HIV care. She has activities related to infectious disease policy, advocacy, and guidelines through her role on the SHEA Guideline Committee, and as the incoming chair of the Infectious Disease Society of America (IDSA) Clinical Affairs Committee, and the IDSA Antimicrobial Stewardship Centers of Excellence Selection Committee.


Disclosures:

S. C. Bleasdale, None

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.